| Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis GM DeNicola, FA Karreth, TJ Humpton, A Gopinathan, C Wei, K Frese, ... Nature 475 (7354), 106-109, 2011 | 2438 | 2011 |
| Organoid models of human and mouse ductal pancreatic cancer SF Boj, CI Hwang, LA Baker, IIC Chio, DD Engle, V Corbo, M Jager, ... Cell 160 (1), 324-338, 2015 | 2146 | 2015 |
| Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts E Elyada, M Bolisetty, P Laise, WF Flynn, ET Courtois, RA Burkhart, ... Cancer discovery 9 (8), 1102-1123, 2019 | 1641 | 2019 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 952 | 2018 |
| Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, ... Jama 318 (9), 825-835, 2017 | 509 | 2017 |
| Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: challenges and recommendations ZI Hu, J Shia, ZK Stadler, AM Varghese, M Capanu, E Salo-Mullen, ... Clinical Cancer Research 24 (6), 1326-1336, 2018 | 387 | 2018 |
| Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA/PALB2 mutation EM O’Reilly, JW Lee, M Zalupski, M Capanu, J Park, T Golan, E Tahover, ... Journal of Clinical Oncology 38 (13), 1378-1388, 2020 | 372 | 2020 |
| An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions MA Lowery, DP Kelsen, ZK Stadler, KH Yu, YY Janjigian, E Ludwig, ... The oncologist 16 (10), 1397-1402, 2011 | 291 | 2011 |
| The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice DD Engle, H Tiriac, KD Rivera, A Pommier, S Whalen, TE Oni, B Alagesan, ... Science 364 (6446), 1156-1162, 2019 | 245 | 2019 |
| Identification of germline genetic mutations in patients with pancreatic cancer EE Salo‐Mullen, EM O'Reilly, DP Kelsen, AM Ashraf, MA Lowery, KH Yu, ... Cancer 121 (24), 4382-4388, 2015 | 237 | 2015 |
| Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms MA Lowery, W Wong, EJ Jordan, JW Lee, Y Kemel, J Vijai, D Mandelker, ... JNCI: Journal of the National Cancer Institute 110 (10), 1067-1074, 2018 | 229 | 2018 |
| Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry KH Yu, AK Rustgi, IA Blair Journal of proteome research 4 (5), 1742-1751, 2005 | 208 | 2005 |
| Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection W Park, J Chen, JF Chou, AM Varghese, KH Yu, W Wong, M Capanu, ... Clinical Cancer Research 26 (13), 3239-3247, 2020 | 201 | 2020 |
| Real-time genomic profiling of pancreatic ductal adenocarcinoma: potential actionability and correlation with clinical phenotype MA Lowery, EJ Jordan, O Basturk, RN Ptashkin, A Zehir, MF Berger, ... Clinical Cancer Research 23 (20), 6094-6100, 2017 | 199 | 2017 |
| Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer M Reyngold, EM O’Reilly, AM Varghese, M Fiasconaro, M Zinovoy, ... JAMA oncology 7 (5), 735-738, 2021 | 161 | 2021 |
| Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma MA Lowery, DP Kelsen, M Capanu, SC Smith, JW Lee, ZK Stadler, ... European Journal of Cancer 89, 19-26, 2018 | 161 | 2018 |
| Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy MA Lowery, DS Klimstra, J Shia, KH Yu, PJ Allen, MF Brennan, ... The oncologist 16 (12), 1714-1720, 2011 | 146 | 2011 |
| Effect of immunoaffinity depletion of human serum during proteomic investigations AK Yocum, K Yu, T Oe, IA Blair Journal of proteome research 4 (5), 1722-1731, 2005 | 144 | 2005 |
| A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas JK Lee, M Capanu, EM O'reilly, J Ma, JF Chou, J Shia, SS Katz, ... British journal of cancer 109 (4), 915-919, 2013 | 132 | 2013 |
| Analysis of the human pancreatic stellate cell secreted proteome AY Wehr, EE Furth, V Sangar, IA Blair, HY Kenneth Pancreas 40 (4), 557-566, 2011 | 118 | 2011 |
Eileen M. O'ReillyMemorial Sloan Kettering Cancer CenterEmail được xác minh tại mskcc.org